TORS

PROCEDURE2 trials

Sponsors

Abramson Cancer Center at Penn Medicine, Centre Hospitalier Universitaire UCLouvain Namur

Conditions

Early Stage (T1-T2, N0-N1,M0)Oropharyngeal CancerSupraglottic Squamous Cell Carcinoma

Phase 2

A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer

CompletedNCT02159703

Abramson Cancer Center at Penn MedicineOropharyngeal Cancer

Start: 2014-02-28End: 2018-02-28Updated: 2019-11-21

Unknown Phase

Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies

RecruitingNCT05611515

Centre Hospitalier Universitaire UCLouvain NamurEarly Stage (T1-T2, N0-N1,M0), Supraglottic Squamous Cell Carcinoma

Start: 2022-06-17End: 2026-12-31Target: 108Updated: 2022-11-10

Related Papers

Treatment of supraglottic squamous cell carcinoma with advanced technologies: observational prospective evaluation of oncological outcomes, functional outcomes, quality of life and cost-effectiveness (SUPRA-QoL).

2023-06-011 citations